Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| PFE | Pfizer Inc. | 3.51% | 52.43 | 0.9% | $1363.76m | |
| JNJ | Johnson & Johnson | 1.74% | 176.97 | 0.7% | $1352.49m | |
| BMY | Bristol-Myers Squibb Co. | 0.36% | 76.23 | 1.0% | $1197.90m | |
| ABBV | AbbVie, Inc. | -0.53% | 150.92 | 1.9% | $1137.44m | |
| MRK | Merck & Co., Inc. | 1.26% | 93.25 | 0.7% | $1136.00m | |
| LLY | Eli Lilly & Co. | 4.49% | 299.11 | 1.1% | $892.99m | |
| AZN | AstraZeneca Plc | 2.59% | 66.21 | 1.0% | $517.65m | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | 0.65% | 141.96 | 0.0% | $458.27m | |
| VERU | Veru, Inc. | -6.37% | 13.38 | 0.0% | $318.66m | |
| NVS | Novartis AG | 0.86% | 89.41 | 0.2% | $251.17m | |
| GSK | GlaxoSmithKline Plc | 2.23% | 44.53 | 0.2% | $243.21m | |
| HZNP | Horizon Therapeutics Plc | 1.13% | 90.35 | 5.4% | $200.40m | |
| NVO | Novo Nordisk A/S | 3.49% | 107.68 | 0.1% | $190.60m | |
| SGEN | Seagen Inc. | -2.10% | 139.64 | 5.7% | $181.75m | |
| VTRS | Viatris, Inc. | 0.94% | 11.80 | 0.0% | $166.13m |
Company Profile
Sunesis Pharmaceuticals, Inc. engages in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. The firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The company was founded on February 10, 1998 and is headquartered in South San Francisco, CA.